Not Signed In -
Benign Intracranial Hypertension |
|
|
Clinical Trial: A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia
This study is no longer recruiting patients.
|
Purpose
The purpose of this trial is to determine the efficacy and safety of an investigational drug in patients with benign prostatic hyperplasia.
| Condition | Intervention | Phase |
|---|---|---|
| Benign Prostatic Hyperplasia | Drug: MK0906 (finasteride) | Phase III |
MedlinePlus related topics: Prostate Diseases
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Eligibility
Ages Eligible for Study: 50 Years - 79 Years, Genders Eligible for Study: Male
Criteria
Inclusion Criteria:
- Patients with benign prostatic hyperplasia
Exclusion Criteria:
- Patients who are suspected to be suffering from prostatic cancer
Location Information
Japan, Chuoku
Call for Site Information, Tokyo, Chuoku, 103-8416, Japan
Study chairs or principal investigators
Medical Monitor, Study Director, Merck
More Information
Study ID Numbers: 2005_042
Last Updated: August 19, 2005
Record first received: August 3, 2005
ClinicalTrials.gov Identifier: NCT00127179
Health Authority: Japan: Ministry of Health, Labor and Welfare
ClinicalTrials.gov processed this record on 2005-08-23
Last Updated: August 19, 2005
Record first received: August 3, 2005
ClinicalTrials.gov Identifier: NCT00127179
Health Authority: Japan: Ministry of Health, Labor and Welfare
ClinicalTrials.gov processed this record on 2005-08-23
Resources
- Benign Intracranial Hypertension (National Institute of Neurological Disorders and Stroke)
email this page
print this page
bookmark this page
feedback on this page
